메뉴 건너뛰기




Volumn , Issue , 2007, Pages 109-150

A practical approach to computational models of the blood-brain barrier

(1)  Adenot, M a  

a Syntem   (France)

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84900931399     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-30380-2_6     Document Type: Chapter
Times cited : (2)

References (163)
  • 1
    • 0028108085 scopus 로고
    • Hydrogen bonding.33 factors that influence the distribution of solutes between blood and brain
    • Abraham MH, Chadha HS, Mitchell RC. 1994. Hydrogen bonding.33 factors that influence the distribution of solutes between blood and brain. J Pharm Sci 83:1257-1268.
    • (1994) J Pharm Sci , vol.83 , pp. 1257-1268
    • Abraham, M.H.1    Chadha, H.S.2    Mitchell, R.C.3
  • 2
    • 1542426103 scopus 로고    scopus 로고
    • Blood-brain barrier permeation model: Discriminating between CNS and non-CNS potential drugs including P-gp substrates
    • Adenot M, Lahana R. 2004. Blood-brain barrier permeation model: Discriminating between CNS and non-CNS potential drugs including P-gp substrates. J Chem Inf Comput Sci 44(1):239-248.
    • (2004) J Chem Inf Comput Sci , vol.44 , Issue.1 , pp. 239-248
    • Adenot, M.1    Lahana, R.2
  • 3
    • 0025867176 scopus 로고
    • Permeability of the blood-brain barrier for atenolol studied by positron emission tomography
    • Agon P, Goethals P, Van Haver D, Kaufman JM. 1991. Permeability of the blood-brain barrier for atenolol studied by positron emission tomography. J Pharm Pharmacol 43:597-600.
    • (1991) J Pharm Pharmacol , vol.43 , pp. 597-600
    • Agon, P.1    Goethals, P.2    Van Haver, D.3    Kaufman, J.M.4
  • 4
    • 0000572720 scopus 로고
    • Pgp substrates diversity among compounds identified by COMPARE analysis in the NCI drug screen
    • Ahkmed N, Fojo AT, Bates SE, Scala S. 1995. Pgp substrates diversity among compounds identified by COMPARE analysis in the NCI drug screen. Proc Am Assoc Cancer Res 36:339.
    • (1995) Proc Am Assoc Cancer Res , vol.36 , pp. 339
    • Ahkmed, N.1    Fojo, A.T.2    Bates, S.E.3    Scala, S.4
  • 5
    • 0033518275 scopus 로고    scopus 로고
    • Designing libraries with CNS activity
    • Ajay, Bemis GW, Murcko MA. 1999. Designing libraries with CNS activity. J Med Chem 42:4942-4951.
    • (1999) J Med Chem , vol.42 , pp. 4942-4951
    • Ajay1    Bemis, G.W.2    Murcko, M.A.3
  • 7
    • 0347301796 scopus 로고    scopus 로고
    • Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: Application to prediction of Caco-2 cell permeability
    • Ano R, Kimura Y, Shima M, Matsuno R, Ueno T, et al. 2004. Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: Application to prediction of Caco-2 cell permeability. Bioorg Med Chem 12:257-264.
    • (2004) Bioorg Med Chem , vol.12 , pp. 257-264
    • Ano, R.1    Kimura, Y.2    Shima, M.3    Matsuno, R.4    Ueno, T.5
  • 9
    • 0034821939 scopus 로고    scopus 로고
    • Role of transport proteins in drug absorption, distribution and excretion
    • Ayrton A, Morgan P. 2001. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31:469-497.
    • (2001) Xenobiotica , vol.31 , pp. 469-497
    • Ayrton, A.1    Morgan, P.2
  • 10
    • 0034676318 scopus 로고    scopus 로고
    • Classification of multidrug-resistance reversal agents using structure-based descriptors and linear discriminant analysis
    • Bakken GA, Jurs PC. 2000. Classification of multidrug-resistance reversal agents using structure-based descriptors and linear discriminant analysis. J Med Chem 43:4534-4541.
    • (2000) J Med Chem , vol.43 , pp. 4534-4541
    • Bakken, G.A.1    Jurs, P.C.2
  • 11
    • 0033820226 scopus 로고    scopus 로고
    • Lipophilicity in trans-bilayer transport and subcellular pharmacokinetics
    • Balaz S. 2000. Lipophilicity in trans-bilayer transport and subcellular pharmacokinetics. Perspect Drug Discov Des 19:157-177.
    • (2000) Perspect Drug Discov des , vol.19 , pp. 157-177
    • Balaz, S.1
  • 12
    • 0029938236 scopus 로고    scopus 로고
    • Predicting blood-brain transport of drugs: A computational approach
    • Basak SC, Gute BD, Drewes LR. 1996. Predicting blood-brain transport of drugs: A computational approach. Pharm Res 13(5):775-778.
    • (1996) Pharm Res , vol.13 , Issue.5 , pp. 775-778
    • Basak, S.C.1    Gute, B.D.2    Drewes, L.R.3
  • 14
    • 0037205138 scopus 로고    scopus 로고
    • In vitro P-glycoprotein affinity for atypical and conventional anti-psychiotics
    • Boulton D, De Vane C, Liston H, Markowitz J. 2002. In vitro P-glycoprotein affinity for atypical and conventional anti-psychiotics. Life Sci 71:163-169.
    • (2002) Life Sci , vol.71 , pp. 163-169
    • Boulton, D.1    De Vane, C.2    Liston, H.3    Markowitz, J.4
  • 15
    • 0036847152 scopus 로고    scopus 로고
    • Intercommunications between brain capillary endothelial cells and glial cells increase the transcellular permeability of the blood-brain barrier during ischemia
    • Brillault J, Berezowski V, Ceccheli R, Dehouck MP. 2002. Intercommunications between brain capillary endothelial cells and glial cells increase the transcellular permeability of the blood-brain barrier during ischemia. J Neurochem 83(4):807-817.
    • (2002) J Neurochem , vol.83 , Issue.4 , pp. 807-817
    • Brillault, J.1    Berezowski, V.2    Ceccheli, R.3    Dehouck, M.P.4
  • 16
    • 0028291586 scopus 로고
    • Predicting the brain-penetrating capability of histaminergic compounds
    • Calder J A D, Ganellin CR. 1994. Predicting the brain-penetrating capability of histaminergic compounds. Drug Des Discov 11:259-268.
    • (1994) Drug Des Discov , vol.11 , pp. 259-268
    • Calder, J.A.D.1    Ganellin, C.R.2
  • 17
    • 0032190504 scopus 로고    scopus 로고
    • Shapes of membrane-permeability-lipophilicity curves: Extension of theoritical models with an aqueous pore pathway
    • Camenish G, Folkers G, Waterbeemd van de H. 1998. Shapes of membrane-permeability-lipophilicity curves: Extension of theoritical models with an aqueous pore pathway. Eur J Pharmacol Sci 6:321-329.
    • (1998) Eur J Pharmacol Sci , vol.6 , pp. 321-329
    • Camenish, G.1    Folkers, G.2    Van De Waterbeemd, H.3
  • 19
    • 0027332629 scopus 로고
    • Structure-activity relationships of serotonin transport: Relevance to non-tricyclic antidepressant interactions
    • Chang AS, Chang SM, Starnes DM. 1993. Structure-activity relationships of serotonin transport: Relevance to non-tricyclic antidepressant interactions. European Journal of Pharmacology 247:239-248.
    • (1993) European Journal of Pharmacology , vol.247 , pp. 239-248
    • Chang, A.S.1    Chang, S.M.2    Starnes, D.M.3
  • 20
    • 0033970317 scopus 로고    scopus 로고
    • Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine
    • Chen N, Jutice Jr JB. 2000. Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine. Molecular Brain Research 75:208-215.
    • (2000) Molecular Brain Research , vol.75 , pp. 208-215
    • Chen, N.1    Jutice Jr., J.B.2
  • 21
    • 0029898576 scopus 로고    scopus 로고
    • Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multiodrug resistance
    • Chiba P, Ecker G, Schmid D, Drach J, Tell B, et al. 1996. Structural requirements for activity of propafenone-type modulators in P-glycoprotein- mediated multiodrug resistance. Mol Pharmacol 49:1122-1130.
    • (1996) Mol Pharmacol , vol.49 , pp. 1122-1130
    • Chiba, P.1    Ecker, G.2    Schmid, D.3    Drach, J.4    Tell, B.5
  • 22
    • 0028270064 scopus 로고
    • Hydrogen-bonding as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides
    • Chikhale EG, Ng KY, Burton PS, Borchardt RT. 1994. Hydrogen-bonding as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm Res 11(3):412-419.
    • (1994) Pharm Res , vol.11 , Issue.3 , pp. 412-419
    • Chikhale, E.G.1    Ng, K.Y.2    Burton, P.S.3    Borchardt, R.T.4
  • 23
    • 0032811868 scopus 로고    scopus 로고
    • Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration
    • Clark DE. 1999. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci 88(8):815-821.
    • (1999) J Pharm Sci , vol.88 , Issue.8 , pp. 815-821
    • Clark, D.E.1
  • 24
    • 0025999171 scopus 로고
    • The influence of peptide structure on transport across Caco-2 cells
    • Conradi RA, Hilgers AR, Ho N F H, Burton PS. 1991. The influence of peptide structure on transport across Caco-2 cells. Pharm Res 8:1453-1460.
    • (1991) Pharm Res , vol.8 , pp. 1453-1460
    • Conradi, R.A.1    Hilgers, A.R.2    Ho, N.F.H.3    Burton, P.S.4
  • 25
    • 0026513211 scopus 로고
    • The influence of peptide structure on transport across Caco-2 cells. II. Peptide modification which results in improved permeability
    • Conradi RA, Hilgers AR, Ho N F H, Burton PS. 1992. The influence of peptide structure on transport across Caco-2 cells. II. Peptide modification which results in improved permeability. Pharm Res 9:435-439.
    • (1992) Pharm Res , vol.9 , pp. 435-439
    • Conradi, R.A.1    Hilgers, A.R.2    Ho, N.F.H.3    Burton, P.S.4
  • 26
    • 0034213636 scopus 로고    scopus 로고
    • Predicting blood-brain permeation from three-dimensional molecular structure
    • Crivori P, Cruciani G, Carrupt P-A, Testa B. 2000. Predicting blood-brain permeation from three-dimensional molecular structure. J Med Chem 43:2204-2216.
    • (2000) J Med Chem , vol.43 , pp. 2204-2216
    • Crivori, P.1    Cruciani, G.2    Carrupt, P.-A.3    Testa, B.4
  • 27
    • 0345415712 scopus 로고    scopus 로고
    • QSAR studies on P-glycoprotein-regulated multidrug resistance and on its reversal by phenothiazines
    • Dearden JC, Al-Noobi A, Scott AC, Thomson SA. 2003. QSAR studies on P-glycoprotein-regulated multidrug resistance and on its reversal by phenothiazines. SAR QSAR Environ Res 14:447-454.
    • (2003) SAR QSAR Environ Res , vol.14 , pp. 447-454
    • Dearden, J.C.1    Al-Noobi, A.2    Scott, A.C.3    Thomson, S.A.4
  • 28
    • 0002359702 scopus 로고
    • Rationally designed model with general applicability for absorption by passive diffusion
    • Seydel JK, editor. Weinheim: VCH
    • De Haan F H N, Jansen A C A. 1985. Rationally designed model with general applicability for absorption by passive diffusion. QSAR and Strategies in the Design of Bioactive Compounds. Seydel JK, editor. Weinheim: VCH; pp. 198-204.
    • (1985) QSAR and Strategies in the Design of Bioactive Compounds , pp. 198-204
    • De Haan, F.H.N.1    Jansen, A.C.A.2
  • 29
    • 0030755944 scopus 로고    scopus 로고
    • A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier
    • Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, et al. 1997. A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier. J Cell Biol 138(4):877-889.
    • (1997) J Cell Biol , vol.138 , Issue.4 , pp. 877-889
    • Dehouck, B.1    Fenart, L.2    Dehouck, M.P.3    Pierce, A.4    Torpier, G.5
  • 30
    • 0028803733 scopus 로고
    • Drug transport to the brain: Comparison between in vitro and in vivo models of the blood-brain barrier
    • Dehouck MP, Dehouck B, Schluep C, Lemaire M, Cecchelli R. 1995. Drug transport to the brain: Comparison between in vitro and in vivo models of the blood-brain barrier. Eur J Pharm Sci 3:357-365.
    • (1995) Eur J Pharm Sci , vol.3 , pp. 357-365
    • Dehouck, M.P.1    Dehouck, B.2    Schluep, C.3    Lemaire, M.4    Cecchelli, R.5
  • 31
    • 0037111301 scopus 로고    scopus 로고
    • In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions
    • Dehouck MP, Cecchelli R, Green AR, Renftel M, Lundquist S. 2002. In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions. Brain Res 955:229-235.
    • (2002) Brain Res , vol.955 , pp. 229-235
    • Dehouck, M.P.1    Cecchelli, R.2    Green, A.R.3    Renftel, M.4    Lundquist, S.5
  • 32
    • 0034672439 scopus 로고    scopus 로고
    • Methodological issues in microdialysis sampling for pharmacokinetic studies
    • de Lange EC, de Boer AG, Breimer DD. 2000. Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv Drug Deliv Rev 45:125-148.
    • (2000) Adv Drug Deliv Rev , vol.45 , pp. 125-148
    • De Lange, E.C.1    De Boer, A.G.2    Breimer, D.D.3
  • 33
    • 0029126861 scopus 로고
    • Exposure of tumor-necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocul-tured with astrocytes induced a delayed increase of permeability and cytoplasmic stress fiber formation of actin
    • Deli MA, Descamps L, Dehouck MP, Cecchelli R, Joo F, et al. 1995. Exposure of tumor-necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells cocul-tured with astrocytes induced a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J Neurosci Res 41(6):717-726.
    • (1995) J Neurosci Res , vol.41 , Issue.6 , pp. 717-726
    • Deli, M.A.1    Descamps, L.2    Dehouck, M.P.3    Cecchelli, R.4    Joo, F.5
  • 34
    • 0031984072 scopus 로고    scopus 로고
    • Trojan peptides: The penetratin system for intracellular delivery
    • Derossi D, Chassaing G, Prochiantz A. 1998. Trojan peptides: The penetratin system for intracellular delivery. Trends Cell Biol 8:84-87.
    • (1998) Trends Cell Biol , vol.8 , pp. 84-87
    • Derossi, D.1    Chassaing, G.2    Prochiantz, A.3
  • 35
    • 0037389801 scopus 로고    scopus 로고
    • Protective effect of glial cells against lipopolysac-charide-mediated blood-brain barrier injury
    • Descamps L, Coisne C, Dehouck B, Cecchelli R, Torpier G. 2003. Protective effect of glial cells against lipopolysac-charide-mediated blood-brain barrier injury. Glia 42(1):46-58.
    • (2003) Glia , vol.42 , Issue.1 , pp. 46-58
    • Descamps, L.1    Coisne, C.2    Dehouck, B.3    Cecchelli, R.4    Torpier, G.5
  • 36
    • 1842535990 scopus 로고    scopus 로고
    • Classification Analysis of P-glycoprotein substrate specificity
    • Didziapetris R, Japertas P, Avdeef A, Petrauskas A. 2003. Classification Analysis of P-glycoprotein substrate specificity. J Drug Target 11(7):391-406.
    • (2003) J Drug Target , vol.11 , Issue.7 , pp. 391-406
    • Didziapetris, R.1    Japertas, P.2    Avdeef, A.3    Petrauskas, A.4
  • 37
    • 84962359573 scopus 로고    scopus 로고
    • High throughput artificial membrane permeability assay for blood-brain barrier
    • Di L, Kerns EH, Fan K, McConnell OJ, Carter GT. 2003. High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem 38:223-232.
    • (2003) Eur J Med Chem , vol.38 , pp. 223-232
    • Di, L.1    Kerns, E.H.2    Fan, K.3    McConnell, O.J.4    Carter, G.T.5
  • 38
    • 12244271454 scopus 로고    scopus 로고
    • Predicting CNS permeability of drug molecules: Comparison of neural network and support vector machine algorithms
    • Doniger S, Hofmann T, Yeh J. 2002. Predicting CNS permeability of drug molecules: Comparison of neural network and support vector machine algorithms. J Comput Biol 9(6):849-864.
    • (2002) J Comput Biol , vol.9 , Issue.6 , pp. 849-864
    • Doniger, S.1    Hofmann, T.2    Yeh, J.3
  • 39
    • 0032885452 scopus 로고    scopus 로고
    • Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein
    • Doppenschmitt S, Spahn-Langguth H, Regardh CG, Lang-guth P. 1999. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. J Pharm Sci 88(10):1067-1072.
    • (1999) J Pharm Sci , vol.88 , Issue.10 , pp. 1067-1072
    • Doppenschmitt, S.1    Spahn-Langguth, H.2    Regardh, C.G.3    Lang-guth, P.4
  • 40
    • 52449102846 scopus 로고    scopus 로고
    • Peptide delivery to the brain via adsorptive-mediated endocytosis: Advances with SynB vectors
    • Drin G, Rousselle C, Schermann JM, Rees AR, Temsamani J. 2002. Peptide delivery to the brain via adsorptive-mediated endocytosis: Advances with SynB vectors. AAPS Pharm Sci 4(4):1-7.
    • (2002) AAPS Pharm Sci , vol.4 , Issue.4 , pp. 1-7
    • Drin, G.1    Rousselle, C.2    Schermann, J.M.3    Rees, A.R.4    Temsamani, J.5
  • 41
    • 0042232110 scopus 로고    scopus 로고
    • Studies on the internalization mechanism of cationic cell-penetrating peptides
    • Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. 2003. Studies on the internalization mechanism of cationic cell-penetrating peptides. J Biol Chem 278(33):31192-31201.
    • (2003) J Biol Chem , vol.278 , Issue.33 , pp. 31192-31201
    • Drin, G.1    Cottin, S.2    Blanc, E.3    Rees, A.R.4    Temsamani, J.5
  • 42
    • 0034728673 scopus 로고    scopus 로고
    • Prediction of properties from simulations: Free energies of solvation in hexadecane, octanol, and water
    • Duffy EM, Jorgensen, WL. 2000. Prediction of properties from simulations: Free energies of solvation in hexadecane, octanol, and water. J Am Chem Soc 122:2878-2888.
    • (2000) J Am Chem Soc , vol.122 , pp. 2878-2888
    • Duffy, E.M.1    Jorgensen, W.L.2
  • 43
    • 0344761958 scopus 로고    scopus 로고
    • The importance of a nitrogen atom in modulators of multidrug resistance
    • Ecker G, Huber M, Schmid D, Chiba P. 1999. The importance of a nitrogen atom in modulators of multidrug resistance. Mol Pharmacol 56:791-796.
    • (1999) Mol Pharmacol , vol.56 , pp. 791-796
    • Ecker, G.1    Huber, M.2    Schmid, D.3    Chiba, P.4
  • 44
    • 18344364851 scopus 로고    scopus 로고
    • Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates
    • Ekins S, Kim RB, Leake BF, Dantzig AH, Schuetz EG, et al. 2002. Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates. Mol Pharmacol 61:974-981.
    • (2002) Mol Pharmacol , vol.61 , pp. 974-981
    • Ekins, S.1    Kim, R.B.2    Leake, B.F.3    Dantzig, A.H.4    Schuetz, E.G.5
  • 45
    • 0037208306 scopus 로고    scopus 로고
    • Prediction of CNS activity of compound libraries using substructure analysis
    • Engkvist O, Wrede P, Rester U. 2003. Prediction of CNS activity of compound libraries using substructure analysis. J Chem Inf Comput Sci 43:155-160.
    • (2003) J Chem Inf Comput Sci , vol.43 , pp. 155-160
    • Engkvist, O.1    Wrede, P.2    Rester, U.3
  • 46
    • 0031819596 scopus 로고    scopus 로고
    • Inhibition of P-glycoprotein: Rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier
    • Fenart L, Buee-Scherrer V, Descamps L, Duhem C, Poullain MG, et al. 1998. Inhibition of P-glycoprotein: Rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier. Pharm Res 15(7):993-1000.
    • (1998) Pharm Res , vol.15 , Issue.7 , pp. 993-1000
    • Fenart, L.1    Buee-Scherrer, V.2    Descamps, L.3    Duhem, C.4    Poullain, M.G.5
  • 47
    • 0031695039 scopus 로고    scopus 로고
    • Blood-brain barrier permeation: Molecular parameters governing passive diffusion
    • Fischer H, Gottschlich R, Seelig A. 1998. Blood-brain barrier permeation: Molecular parameters governing passive diffusion. J Membr Biol 165:201-211.
    • (1998) J Membr Biol , vol.165 , pp. 201-211
    • Fischer, H.1    Gottschlich, R.2    Seelig, A.3
  • 48
    • 0036392720 scopus 로고    scopus 로고
    • Stereospecific inhibition of monoamine uptake transporters by meta-hydroxyephedrine isomers
    • Foley KF, Van Dort ME, Sievert MK, Ruoho AE, Cozzi NV. 2002. Stereospecific inhibition of monoamine uptake transporters by meta-hydroxyephedrine isomers. J Neural Transm 109(10):1229-40.
    • (2002) J Neural Transm , vol.109 , Issue.10 , pp. 1229-1240
    • Foley, K.F.1    Van Dort, M.E.2    Sievert, M.K.3    Ruoho, A.E.4    Cozzi, N.V.5
  • 49
    • 0024534226 scopus 로고
    • Structural features determining activity of phenothiazines and related drugs for inhibition of cell-growth and reversal of multidrug resistance
    • Ford JM, Prozialeck WC, Hait WN. 1989. Structural features determining activity of phenothiazines and related drugs for inhibition of cell-growth and reversal of multidrug resistance. Mol Pharmacol 35:105-115.
    • (1989) Mol Pharmacol , vol.35 , pp. 105-115
    • Ford, J.M.1    Prozialeck, W.C.2    Hait, W.N.3
  • 50
    • 0037802511 scopus 로고    scopus 로고
    • Bypassing the blood-brain barrier to deliver therapeutic agents to the brain and spinal cord
    • Frey WH, 2002. Bypassing the blood-brain barrier to deliver therapeutic agents to the brain and spinal cord. Drug Deliv Technol 2:5.
    • (2002) Drug Deliv Technol , vol.2 , pp. 5
    • Frey, W.H.1
  • 51
    • 1242291861 scopus 로고    scopus 로고
    • Predicting blood-brain barrier penetration of drugs using an artificial neural network
    • Fu XC, Wang GP, Liang WQ, Yu QS. 2004. Predicting blood-brain barrier penetration of drugs using an artificial neural network. Farmazie 59:126-130.
    • (2004) Farmazie , vol.59 , pp. 126-130
    • Fu, X.C.1    Wang, G.P.2    Liang, W.Q.3    Yu, Q.S.4
  • 52
    • 0033673170 scopus 로고    scopus 로고
    • Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astro-cytes
    • Gaillard PJ, Voordwinden LH, Nielsen JL, Ivanov A, Atsumi R, et al. 2001. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astro-cytes. Eur J Pharm Sci 12:215-222.
    • (2001) Eur J Pharm Sci , vol.12 , pp. 215-222
    • Gaillard, P.J.1    Voordwinden, L.H.2    Nielsen, J.L.3    Ivanov, A.4    Atsumi, R.5
  • 53
    • 0029077098 scopus 로고
    • Central and peripheral analgesic agents: Chemical strategies for limiting brain penetration in Kappa-Opioid agonists belonging to different chemical classes
    • Giardina G, Clarke GD, Grugni M, Sbacchi M, Vecchietti V. 1995. Central and peripheral analgesic agents: Chemical strategies for limiting brain penetration in Kappa-Opioid agonists belonging to different chemical classes. Il Farmaco 50(6):405-418.
    • (1995) Il Farmaco , vol.50 , Issue.6 , pp. 405-418
    • Giardina, G.1    Clarke, G.D.2    Grugni, M.3    Sbacchi, M.4    Vecchietti, V.5
  • 54
    • 0031946993 scopus 로고    scopus 로고
    • In vitro blood-brain barrier permeability of nevirapine compared to other HIV antire-troviral agents
    • Glynn SL, Yazdanian M. 1998. In vitro blood-brain barrier permeability of nevirapine compared to other HIV antire-troviral agents. J Pharm Sci 87(3):306-310.
    • (1998) J Pharm Sci , vol.87 , Issue.3 , pp. 306-310
    • Glynn, S.L.1    Yazdanian, M.2
  • 55
    • 1842586876 scopus 로고    scopus 로고
    • Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model
    • Gombar VK, Polli JW, Humphreys JE, Wring SA, Serabjit-Singh CS. 2004. Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model. J Pharm Sci 93(4):957-968.
    • (2004) J Pharm Sci , vol.93 , Issue.4 , pp. 957-968
    • Gombar, V.K.1    Polli, J.W.2    Humphreys, J.E.3    Wring, S.A.4    Serabjit-Singh, C.S.5
  • 56
    • 0031464488 scopus 로고    scopus 로고
    • Molecular factors influencing drug transfer across the blood-brain barrier
    • Gratton JA, Abraham MH, Bradbury MW, Chadh S. 1997. Molecular factors influencing drug transfer across the blood-brain barrier. J Pharm Pharmacol 49:1211-1216.
    • (1997) J Pharm Pharmacol , vol.49 , pp. 1211-1216
    • Gratton, J.A.1    Abraham, M.H.2    Bradbury, M.W.3    Chadh, S.4
  • 57
    • 0031475151 scopus 로고    scopus 로고
    • The entry of antiviral and antiretroviral drugs into the central nervous system
    • Groothuis DR, Levy RM. 1997. The entry of antiviral and antiretroviral drugs into the central nervous system. J Neurovirol 3(6):387-400.
    • (1997) J Neurovirol , vol.3 , Issue.6 , pp. 387-400
    • Groothuis, D.R.1    Levy, R.M.2
  • 59
    • 0035156232 scopus 로고    scopus 로고
    • Progress and limitations inthe use of in vitro cell cultures to serve as permeability screen for the blood-brain barrier
    • Gumbleton M, Audus KL. 2001. Progress and limitations inthe use of in vitro cell cultures to serve as permeability screen for the blood-brain barrier. J Pharm Sci 90(11):1681-1698.
    • (2001) J Pharm Sci , vol.90 , Issue.11 , pp. 1681-1698
    • Gumbleton, M.1    Audus, K.L.2
  • 60
    • 0030898087 scopus 로고    scopus 로고
    • Drug equilibration across the blood-brain barrier-phar-macokinetic considerations based on the microdialysis method
    • Hammarlund-Udenaes M, Paalzow LK, De Lange E C M. 1997. Drug equilibration across the blood-brain barrier-phar-macokinetic considerations based on the microdialysis method. Pharm Res 14(2):128-134.
    • (1997) Pharm Res , vol.14 , Issue.2 , pp. 128-134
    • Hammarlund-Udenaes, M.1    Paalzow, L.K.2    De Lange, E.C.M.3
  • 61
    • 0029295070 scopus 로고
    • Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes
    • Harwig SS, Swiderek KM, Lee TD, Lehrer RI. 1995. Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes. J Pept Sci 1:207-215.
    • (1995) J Pept Sci , vol.1 , pp. 207-215
    • Harwig, S.S.1    Swiderek, K.M.2    Lee, T.D.3    Lehrer, R.I.4
  • 62
    • 0023192524 scopus 로고
    • Peptide quantitative structure-activity relationships, a multivariate approach
    • Hellberg S, Sjöström M, Skagerberg B, Wold S. 1987. Peptide quantitative structure-activity relationships, a multivariate approach. J Med Chem 30(7):1126-1135.
    • (1987) J Med Chem , vol.30 , Issue.7 , pp. 1126-1135
    • Hellberg, S.1    Sjöström, M.2    Skagerberg, B.3    Wold, S.4
  • 63
    • 0345117308 scopus 로고    scopus 로고
    • ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors
    • Hou TJ, Xu XJ. 2003. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors. J Chem Inf Comput Sci 43(6):2137-2152.
    • (2003) J Chem Inf Comput Sci , vol.43 , Issue.6 , pp. 2137-2152
    • Hou, T.J.1    Xu, X.J.2
  • 64
    • 0344703614 scopus 로고    scopus 로고
    • Prediction of blood-brain barrier permeation using quantum chemically derived information
    • Hutter MC. 2003. Prediction of blood-brain barrier permeation using quantum chemically derived information. J Comput Aided Mol Des 17:415-433.
    • (2003) J Comput Aided Mol des , vol.17 , pp. 415-433
    • Hutter, M.C.1
  • 65
    • 0034095651 scopus 로고    scopus 로고
    • Transport of drugs from the nasal cavity to the central nervous system
    • Illum L. 2000. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1-18.
    • (2000) Eur J Pharm Sci , vol.11 , pp. 1-18
    • Illum, L.1
  • 66
    • 0036896831 scopus 로고    scopus 로고
    • Nasal drug developments and strategies
    • Illum L. 2002. Nasal drug developments and strategies. Drug Des Today 7:1184-1189.
    • (2002) Drug Des Today , vol.7 , pp. 1184-1189
    • Illum, L.1
  • 67
    • 0033059802 scopus 로고    scopus 로고
    • Dynamic in vitro modelling of the blood-brain barrier: A novel tool for studies of drug delivery to the brain
    • Janigro D, Leaman S, Stanness KA, 1999. Dynamic in vitro modelling of the blood-brain barrier: A novel tool for studies of drug delivery to the brain. Pharmacol Sci Technol Today 2(1):7-12.
    • (1999) Pharmacol Sci Technol Today , vol.2 , Issue.1 , pp. 7-12
    • Janigro, D.1    Leaman, S.2    Stanness, K.A.3
  • 68
  • 69
    • 0034608316 scopus 로고    scopus 로고
    • Prediction of drug solubility from Monte Carlo simulations
    • Jorgensen WL, Duffy EM. 2000. Prediction of drug solubility from Monte Carlo simulations. Bioorg Med Chem Lett 10(11):1155-1158.
    • (2000) Bioorg Med Chem Lett , vol.10 , Issue.11 , pp. 1155-1158
    • Jorgensen, W.L.1    Duffy, E.M.2
  • 70
    • 0029976739 scopus 로고    scopus 로고
    • Thermodynamic aspects of hydrophobicity and the blood-brain barrier permeability studied with a gel filtration chromatography
    • Kai J. 1996. Thermodynamic aspects of hydrophobicity and the blood-brain barrier permeability studied with a gel filtration chromatography. J Med Chem 39:2621-2624.
    • (1996) J Med Chem , vol.39 , pp. 2621-2624
    • Kai, J.1
  • 71
    • 0030426820 scopus 로고    scopus 로고
    • Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier
    • Kakee A, Terasaki T, Sugiyama Y. 1996. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. J Pharmacol Exp Ther 277:1550-1559.
    • (1996) J Pharmacol Exp Ther , vol.277 , pp. 1550-1559
    • Kakee, A.1    Terasaki, T.2    Sugiyama, Y.3
  • 72
    • 0032568397 scopus 로고    scopus 로고
    • Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes
    • Kansy M, Senner F, Gubernator K. 1998. Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 41(7):1007-1010.
    • (1998) J Med Chem , vol.41 , Issue.7 , pp. 1007-1010
    • Kansy, M.1    Senner, F.2    Gubernator, K.3
  • 73
    • 0034751672 scopus 로고    scopus 로고
    • Prediction of blood-brain partitioning using Monte-Carlo simulations of molecules in water
    • Kaznessis YN, Snow ME, Blankley CJ. 2001. Prediction of blood-brain partitioning using Monte-Carlo simulations of molecules in water. J Comput Aided Mol Des 15:697-708.
    • (2001) J Comput Aided Mol des , vol.15 , pp. 697-708
    • Kaznessis, Y.N.1    Snow, M.E.2    Blankley, C.J.3
  • 74
    • 0032714220 scopus 로고    scopus 로고
    • Polar Molecular surface as a dominating determinant for oral absorption and brain penetration of drugs
    • Kelder J, Grootenhuis P D J, Bayada DM, Delbressine L P C, Ploemen JP. 1999. Polar Molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res 16:1514-1519.
    • (1999) Pharm Res , vol.16 , pp. 1514-1519
    • Kelder, J.1    Grootenhuis, P.D.J.2    Bayada, D.M.3    Delbressine, L.P.C.4    Ploemen, J.P.5
  • 75
    • 0035227969 scopus 로고    scopus 로고
    • High-througput prediction of blood-brain partitioning: A thermodynamic approach
    • Keserü GM, Molnar L. 2001. High-througput prediction of blood-brain partitioning: A thermodynamic approach. J Chem Inf Comput Sci 41:120-128.
    • (2001) J Chem Inf Comput Sci , vol.41 , pp. 120-128
    • Keserü, G.M.1    Molnar, L.2
  • 76
    • 0026739494 scopus 로고
    • Structure-activity study and design of multidrug-resistant reversal compoundsbya computerautomated structure evaluation methodology
    • Klopman G, Srivastava S, Kolossvary I, Epoand RF, Ahmed N, et al. 1992. Structure-activity study and design of multidrug-resistant reversal compoundsbya computerautomated structure evaluation methodology. Cancer Res 52:4121-4129.
    • (1992) Cancer Res , vol.52 , pp. 4121-4129
    • Klopman, G.1    Srivastava, S.2    Kolossvary, I.3    Epoand, R.F.4    Ahmed, N.5
  • 77
    • 0030800078 scopus 로고    scopus 로고
    • Quantitative structure-activity relationship of multidrug resistance reversal agents
    • Klopman G, Shi LM, Ramu A. 1997. Quantitative structure-activity relationship of multidrug resistance reversal agents. Molecular Pharmacology 52:323-334.
    • (1997) Molecular Pharmacology , vol.52 , pp. 323-334
    • Klopman, G.1    Shi, L.M.2    Ramu, A.3
  • 78
    • 0018624198 scopus 로고
    • Lipophilicity and drug activity
    • Kubinyi H. 1979. Lipophilicity and drug activity. Prog Drug Res 23:97-198.
    • (1979) Prog Drug Res , vol.23 , pp. 97-198
    • Kubinyi, H.1
  • 79
    • 0019124032 scopus 로고
    • Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability
    • Levin VA. 1980. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23:682-684.
    • (1980) J Med Chem , vol.23 , pp. 682-684
    • Levin, V.A.1
  • 80
    • 0035289779 scopus 로고    scopus 로고
    • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv Drug Deliv Rev 46:3-25.
    • (2001) Adv Drug Deliv Rev , vol.46 , pp. 3-25
    • Lipinski, C.A.1    Lombardo, F.2    Dominy, B.W.3    Feeney, P.J.4
  • 81
    • 0030791978 scopus 로고    scopus 로고
    • Structure-activity relationships of P-glycoprotein interacting drugs: Kinetic characterization of their effects on ATP-ase activity
    • Litman T, Zuthen T, Skovsgaard T, Stein W. 1997. Structure-activity relationships of P-glycoprotein interacting drugs: Kinetic characterization of their effects on ATP-ase activity. Biochim Biophys Acta 1361:159-168.
    • (1997) Biochim Biophys Acta , vol.1361 , pp. 159-168
    • Litman, T.1    Zuthen, T.2    Skovsgaard, T.3    Stein, W.4
  • 82
    • 0035498339 scopus 로고    scopus 로고
    • Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration
    • Liu R, Sun H, So S. 2001. Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration. J Chem Inf Comput Sci 41:1623-1632.
    • (2001) J Chem Inf Comput Sci , vol.41 , pp. 1623-1632
    • Liu, R.1    Sun, H.2    So, S.3
  • 83
    • 0037309942 scopus 로고    scopus 로고
    • Recent advances in the prediction of blood-brain partitioning from molecular structure
    • Lobell M, Molnar L, Keserü GM. 2003. Recent advances in the prediction of blood-brain partitioning from molecular structure. J Pharm Sci 92(2):360-370.
    • (2003) J Pharm Sci , vol.92 , Issue.2 , pp. 360-370
    • Lobell, M.1    Molnar, L.2    Keserü, G.M.3
  • 84
    • 0030462889 scopus 로고    scopus 로고
    • Computation of brain-blood partitioning of organic solutes via free-energy calculations
    • Lombardo F, Blake JF, Curatolo W. 1996. Computation of brain-blood partitioning of organic solutes via free-energy calculations. J Med Chem 39:4750-4755.
    • (1996) J Med Chem , vol.39 , pp. 4750-4755
    • Lombardo, F.1    Blake, J.F.2    Curatolo, W.3
  • 86
    • 0033088690 scopus 로고    scopus 로고
    • Prediction of the brain-blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling
    • Luco JM. 1999. Prediction of the brain-blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling. J Chem Inf Comput Sci 39:396-404.
    • (1999) J Chem Inf Comput Sci , vol.39 , pp. 396-404
    • Luco, J.M.1
  • 87
    • 0035997330 scopus 로고    scopus 로고
    • Prediction of drug transport through the blood-brain barrier in vivo: A comparison between two in vitro cell models
    • Lundquist S, Renftel M, Brillault J, Fenart L, Cecchelli R, et al. 2002. Prediction of drug transport through the blood-brain barrier in vivo: A comparison between two in vitro cell models. Pharm Res 19(7):976-981.
    • (2002) Pharm Res , vol.19 , Issue.7 , pp. 976-981
    • Lundquist, S.1    Renftel, M.2    Brillault, J.3    Fenart, L.4    Cecchelli, R.5
  • 88
    • 0141671728 scopus 로고    scopus 로고
    • (R) - and (S)-[11C]Verapamil as PET-tracers for measuring P-glycoprotein function: In vitro and in vivo evaluation
    • Luurtsema G, Molthoff C F M, Windhorst AD, Smit JW, Keizer H, et al. 2003. (R) - and (S)-[11C]Verapamil as PET-tracers for measuring P-glycoprotein function: In vitro and in vivo evaluation. Nucl Med Biol 30:747-751.
    • (2003) Nucl Med Biol , vol.30 , pp. 747-751
    • Luurtsema, G.1    Molthoff, C.F.M.2    Windhorst, A.D.3    Smit, J.W.4    Keizer, H.5
  • 89
    • 0034434249 scopus 로고    scopus 로고
    • Theoritical pharmacoki-netic and pharmacodynamic simulations of drug delivery mediated by blood-brain barrier transporters
    • Mahar Doan KM, Boje K M K. 2000. Theoritical pharmacoki-netic and pharmacodynamic simulations of drug delivery mediated by blood-brain barrier transporters. Biopharm Drug Dispos 21:261-278.
    • (2000) Biopharm Drug Dispos , vol.21 , pp. 261-278
    • Mahar Doan, K.M.1    Boje, K.M.K.2
  • 90
    • 0036896304 scopus 로고    scopus 로고
    • Passive permeability and P-glyco-protein mediated efflux differentiate CNS and non-CNS marketed drugs
    • Mahar Doan KM, Humphreys JE, Webster LO, Wring SA, Shampine LJ, et al. 2002. Passive permeability and P-glyco-protein mediated efflux differentiate CNS and non-CNS marketed drugs. J Pharmacol Exp Ther 303:1029-1037.
    • (2002) J Pharmacol Exp Ther , vol.303 , pp. 1029-1037
    • Mahar Doan, K.M.1    Humphreys, J.E.2    Webster, L.O.3    Wring, S.A.4    Shampine, L.J.5
  • 91
    • 0037203976 scopus 로고    scopus 로고
    • Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclo-phenamic acids, liable to increase neurotropic activity
    • Manfredini S, Pavan B, Vertuani S, Scaglianti M, Compag-none D, et al. 2002. Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclo-phenamic acids, liable to increase neurotropic activity. J Med Chem 45(3):559-562.
    • (2002) J Med Chem , vol.45 , Issue.3 , pp. 559-562
    • Manfredini, S.1    Pavan, B.2    Vertuani, S.3    Scaglianti, M.4    Compag-none, D.5
  • 92
    • 0642280830 scopus 로고    scopus 로고
    • Dynamic in vitro model of the blood-brain barrier. Gene profiling using cDNA microarray analysis
    • Marroni M, Kight KM, Hossain M, Cucullo L, Desai SY, et al. 2003. Dynamic in vitro model of the blood-brain barrier. Gene profiling using cDNA microarray analysis. Methods Mol Med 89:419-434.
    • (2003) Methods Mol Med , vol.89 , pp. 419-434
    • Marroni, M.1    Kight, K.M.2    Hossain, M.3    Cucullo, L.4    Desai, S.Y.5
  • 93
    • 1042266257 scopus 로고    scopus 로고
    • Prediction of blood-brain barrier penetration: Are we missing the point?
    • Martin I. 2004. Prediction of blood-brain barrier penetration: Are we missing the point? Drug Discov Today 9:161-162.
    • (2004) Drug Discov Today , vol.9 , pp. 161-162
    • Martin, I.1
  • 95
    • 0037081556 scopus 로고    scopus 로고
    • A co-culture-based model of human blood-brain barrier: Application to active transport of indin-avir and in vivo-in vitro correlation
    • Megard I, Garrigues A, Orlowski S, Jorajuria S, Clayette, Ezan E, Mabondzo A. 2002. A co-culture-based model of human blood-brain barrier: Application to active transport of indin-avir and in vivo-in vitro correlation. Brain Res 927:153-167.
    • (2002) Brain Res , vol.927 , pp. 153-167
    • Megard, I.1    Garrigues, A.2    Orlowski, S.3    Jorajuria, S.4    Clayette5    Ezan, E.6    Mabondzo, A.7
  • 96
    • 0347525827 scopus 로고    scopus 로고
    • Confocal imaging of xenobiotic transport across the blood-brain barrier
    • Miller DS. 2003. Confocal imaging of xenobiotic transport across the blood-brain barrier. J Exp Zoolog A 300:84-90.
    • (2003) J Exp Zoolog A , vol.300 , pp. 84-90
    • Miller, D.S.1
  • 97
    • 0034028932 scopus 로고    scopus 로고
    • Affinities at the verapamil binding site of MDR-1-encoded P-glycoprotein: Drugs and analogs, stereoisomers and metabolites
    • Neuhoff S, Langguth P, Dressler C, Andersson TB, Regardh CG, et al. 2000. Affinities at the verapamil binding site of MDR-1-encoded P-glycoprotein: Drugs and analogs, stereoisomers and metabolites. Int J Clin Pharmacol Ther 293:376-382.
    • (2000) Int J Clin Pharmacol Ther , vol.293 , pp. 376-382
    • Neuhoff, S.1    Langguth, P.2    Dressler, C.3    Andersson, T.B.4    Regardh, C.G.5
  • 98
    • 0037204545 scopus 로고    scopus 로고
    • Computational approaches to the prediction of blood-brain distribution
    • Norinder U, Haeberlein M. 2002. Computational approaches to the prediction of blood-brain distribution. Adv Drug Deliv Rev 54(3):291-313.
    • (2002) Adv Drug Deliv Rev , vol.54 , Issue.3 , pp. 291-313
    • Norinder, U.1    Haeberlein, M.2
  • 99
    • 0031827249 scopus 로고    scopus 로고
    • Theoritical calculations and prediction of brain-blood partitionning of organic solutes using mol surf parametrization and PLS statistics
    • Norinder U, Sjöberg P, Osterberg T. 1998. Theoritical calculations and prediction of brain-blood partitionning of organic solutes using mol surf parametrization and PLS statistics. J Pharm Sci 88:815-821.
    • (1998) J Pharm Sci , vol.88 , pp. 815-821
    • Norinder, U.1    Sjöberg, P.2    Osterberg, T.3
  • 100
    • 0037130275 scopus 로고    scopus 로고
    • A simple model to predict blood-brain barrier permeation from 3D molecular fields
    • Ooms F, Weber P, Carrupt PA, Testa B. 2002. A simple model to predict blood-brain barrier permeation from 3D molecular fields. Biochim Biophys Acta 1587:118-125.
    • (2002) Biochim Biophys Acta , vol.1587 , pp. 118-125
    • Ooms, F.1    Weber, P.2    Carrupt, P.A.3    Testa, B.4
  • 101
    • 0034077338 scopus 로고    scopus 로고
    • Theoritical calculation and prediction of p-glycoprotein-interacting drugs using mol surf parametrization and PLS Statistics
    • Osterberg T, Norinder U. 2000a. Theoritical calculation and prediction of p-glycoprotein-interacting drugs using mol surf parametrization and PLS Statistics. Eur J Pharm Sci 10:295-303.
    • (2000) Eur J Pharm Sci , vol.10 , pp. 295-303
    • Osterberg, T.1    Norinder, U.2
  • 102
    • 0034320657 scopus 로고    scopus 로고
    • Prediction of polar surface area and drug transport processes using simple parameters and PLS statistics
    • Osterberg T, Norinder U. 2000b. Prediction of polar surface area and drug transport processes using simple parameters and PLS statistics. J Chem Inf Comput Sci 40:1408-1411.
    • (2000) J Chem Inf Comput Sci , vol.40 , pp. 1408-1411
    • Osterberg, T.1    Norinder, U.2
  • 103
    • 0030898431 scopus 로고    scopus 로고
    • QSAR and molecular modelling of catamphiphilic drugs able to modulate multidrug resistance in tumors
    • Pajeva I, Wiese M. 1997. QSAR and molecular modelling of catamphiphilic drugs able to modulate multidrug resistance in tumors. Quant Struct-Act Relat 16:1-10.
    • (1997) Quant Struct-act Relat , vol.16 , pp. 1-10
    • Pajeva, I.1    Wiese, M.2
  • 104
    • 0032554868 scopus 로고    scopus 로고
    • Molecular modelling of phenothia-zines and related drugs as multidrug resistance modifiers: A comparative molecular fields analysis study
    • Pajeva I, Wiese M. 1998. Molecular modelling of phenothia-zines and related drugs as multidrug resistance modifiers: A comparative molecular fields analysis study. J Med Chem 41:1815-1826.
    • (1998) J Med Chem , vol.41 , pp. 1815-1826
    • Pajeva, I.1    Wiese, M.2
  • 105
    • 0037137614 scopus 로고    scopus 로고
    • Pharmacophore model of drugs incolved in P-glycoprotein multidrug resistance: Explanation of structural variety (Hypothesis)
    • Pajeva I, Wiese M. 2002. Pharmacophore model of drugs incolved in P-glycoprotein multidrug resistance: Explanation of structural variety (Hypothesis). J Med Chem 45:5671-5686.
    • (2002) J Med Chem , vol.45 , pp. 5671-5686
    • Pajeva, I.1    Wiese, M.2
  • 106
    • 0032585545 scopus 로고    scopus 로고
    • Evaluation of dynamic polar molecular surface area as predictor of drug absorption: Comparison with other computational and experimental predictors
    • Palm K, Luthman K, Ungell AL, Strandlund G, Beigi F, et al. 1998. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: Comparison with other computational and experimental predictors. J Med Chem 41(27):5382-5392.
    • (1998) J Med Chem , vol.41 , Issue.27 , pp. 5382-5392
    • Palm, K.1    Luthman, K.2    Ungell, A.L.3    Strandlund, G.4    Beigi, F.5
  • 107
    • 0031959341 scopus 로고    scopus 로고
    • CNS drug design based on principles of blood-brain barrier transport
    • Pardridge WM. 1998. CNS drug design based on principles of blood-brain barrier transport. J Neurochem 70(5):1781-1792.
    • (1998) J Neurochem , vol.70 , Issue.5 , pp. 1781-1792
    • Pardridge, W.M.1
  • 108
    • 0036463371 scopus 로고    scopus 로고
    • Drug and gene targetingtothe brainwith molecular Trojan horses
    • Pardridge WM. 2002. Drug and gene targetingtothe brainwith molecular Trojan horses. Nat Rev Drug Discov 1:131-139.
    • (2002) Nat Rev Drug Discov , vol.1 , pp. 131-139
    • Pardridge, W.M.1
  • 109
    • 1842635478 scopus 로고    scopus 로고
    • Log (BB), PS products and in silico models of drug brain penetration
    • Pardridge WM. 2004. Log (BB), PS products and in silico models of drug brain penetration. Drug Discov Today 9:392-393.
    • (2004) Drug Discov Today , vol.9 , pp. 392-393
    • Pardridge, W.M.1
  • 110
    • 0018750857 scopus 로고
    • Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone
    • Pardridge WM, Mietus LJ. 1979. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest 64:145-154.
    • (1979) J Clin Invest , vol.64 , pp. 145-154
    • Pardridge, W.M.1    Mietus, L.J.2
  • 111
    • 0038303407 scopus 로고    scopus 로고
    • Use of a three-dimensional in vitro model of teh rat blood-brain barrier to assay nucleoside efflux from brain
    • Parkinson FE, Friesen J, Krizanac-Bengez L, Janigro D. 2003. Use of a three-dimensional in vitro model of teh rat blood-brain barrier to assay nucleoside efflux from brain. Brain Res 980:233-241.
    • (2003) Brain Res , vol.980 , pp. 233-241
    • Parkinson, F.E.1    Friesen, J.2    Krizanac-Bengez, L.3    Janigro, D.4
  • 112
    • 0025059269 scopus 로고
    • Structural characteristics of compounds that modulates P-glycoprotein-associated multidrug resistance
    • Pearce HL, Winter MA, Beck WT. 1990. Structural characteristics of compounds that modulates P-glycoprotein-associated multidrug resistance. Adv Enzyme Regul 30:357-373.
    • (1990) Adv Enzyme Regul , vol.30 , pp. 357-373
    • Pearce, H.L.1    Winter, M.A.2    Beck, W.T.3
  • 113
    • 0037171818 scopus 로고    scopus 로고
    • A computational ensemble P harmacophore model for identifying substrates of P-glycoprotein
    • Penzotti JE, Lamb ML, Evensen E, Grootenhuis P D J. 2002. A computational ensemble P harmacophore model for identifying substrates of P-glycoprotein. J Med Chem 45(9):1737-1740.
    • (2002) J Med Chem , vol.45 , Issue.9 , pp. 1737-1740
    • Penzotti, J.E.1    Lamb, M.L.2    Evensen, E.3    Grootenhuis, P.D.J.4
  • 114
    • 84900942419 scopus 로고    scopus 로고
    • HIV infection and the blood-brain barrier
    • Pardridge WM, editor. UK: Cambridge University Press
    • Petito CK, 1998. HIV infection and the blood-brain barrier. Pardridge WM, Introduction to the Blood-Brain Barrier. Pardridge WM, editor. UK: Cambridge University Press.
    • (1998) Pardridge WM, Introduction to the Blood-brain Barrier
    • Petito, C.K.1
  • 115
    • 0028822474 scopus 로고
    • Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer
    • Plateel M, Dehouck MP, Torpier G, Cecchelli R, Teissier E. 1995. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J Neurochem 65(5):2138-2145.
    • (1995) J Neurochem , vol.65 , Issue.5 , pp. 2138-2145
    • Plateel, M.1    Dehouck, M.P.2    Torpier, G.3    Cecchelli, R.4    Teissier, E.5
  • 116
    • 0035440324 scopus 로고    scopus 로고
    • Correlation and prediction of a large blood-brain distribution data set-an LFER study
    • Platts JA, Abraham MH, Zhao YH, Hersey A, Ijaz L, et al. 2001. Correlation and prediction of a large blood-brain distribution data set-an LFER study. Eur J Med Chem 36:719-730.
    • (2001) Eur J Med Chem , vol.36 , pp. 719-730
    • Platts, J.A.1    Abraham, M.H.2    Zhao, Y.H.3    Hersey, A.4    Ijaz, L.5
  • 118
    • 0031728078 scopus 로고    scopus 로고
    • Peptide drug delivery into the central nervous system
    • Prokai L. 1998. Peptide drug delivery into the central nervous system. Prog Drug Res 51:95-131.
    • (1998) Prog Drug Res , vol.51 , pp. 95-131
    • Prokai, L.1
  • 119
    • 0032321367 scopus 로고    scopus 로고
    • Quantitative estimation of hydrogen bond contribution to permeability and absorption processes of some chemicals and drugs
    • Raevsky OA, Schaper KJ. 1998. Quantitative estimation of hydrogen bond contribution to permeability and absorption processes of some chemicals and drugs. Eur J Med Chem 33:799-807.
    • (1998) Eur J Med Chem , vol.33 , pp. 799-807
    • Raevsky, O.A.1    Schaper, K.J.2
  • 120
    • 0026624915 scopus 로고
    • Reversal of multidrug resistance by phenothiazines and structurally related compounds
    • Ramu A, Ramu N. 1992. Reversal of multidrug resistance by phenothiazines and structurally related compounds. Cancer Chemother Pharmacol 30:165-173.
    • (1992) Cancer Chemother Pharmacol , vol.30 , pp. 165-173
    • Ramu, A.1    Ramu, N.2
  • 121
    • 0016284341 scopus 로고
    • Neurotoxicity of X-ray contrast media. Relation to lipid solubility and blood-brain barrier permeability
    • Rapoport SI, Levitan H. 1974. Neurotoxicity of X-ray contrast media. Relation to lipid solubility and blood-brain barrier permeability. Am J Roentgenol Radium Ther Nucl Med 122(1):186-193.
    • (1974) Am J Roentgenol Radium Ther Nucl Med , vol.122 , Issue.1 , pp. 186-193
    • Rapoport, S.I.1    Levitan, H.2
  • 122
    • 0036557847 scopus 로고    scopus 로고
    • Modeling blood-brain barrier partitioning using the electrotopological state
    • Rose K, Hall LH, Kier LB. 2002. Modeling blood-brain barrier partitioning using the electrotopological state. J Chem Inf Comput Sci 42:651-666.
    • (2002) J Chem Inf Comput Sci , vol.42 , pp. 651-666
    • Rose, K.1    Hall, L.H.2    Kier, L.B.3
  • 123
    • 0034126420 scopus 로고    scopus 로고
    • New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy
    • Rousselle C, Clair P, Lefauconnier JM, Kaczoreck M, Scherr-mann JM, et al. 2000. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol Pharmacol 57:679-686.
    • (2000) Mol Pharmacol , vol.57 , pp. 679-686
    • Rousselle, C.1    Clair, P.2    Lefauconnier, J.M.3    Kaczoreck, M.4    Scherr-mann, J.M.5
  • 124
    • 0035196836 scopus 로고    scopus 로고
    • Enhanced delivery of doxorubicin intothe brain via a peptide-vector- mediated strategy: Saturation kinetics and specificity
    • Rousselle C, Smirnova M, Clair P, Lefauconnier JM, Chava-nieu A, et al. 2001. Enhanced delivery of doxorubicin intothe brain via a peptide-vector- mediated strategy: Saturation kinetics and specificity. J Pharmacol Exp Ther 296(1):124-131.
    • (2001) J Pharmacol Exp Ther , vol.296 , Issue.1 , pp. 124-131
    • Rousselle, C.1    Smirnova, M.2    Clair, P.3    Lefauconnier, J.M.4    Chava-nieu, A.5
  • 125
    • 0342676461 scopus 로고    scopus 로고
    • Regulation of brain endothelial cell tight junction permeability
    • Pardridge WM, editor. Cambridge: Cambridge University Press
    • Rubin L, Morgan L, Staddon JM. 1998. Regulation of brain endothelial cell tight junction permeability. Introduction to the Blood-Brain Barrier. Pardridge WM, editor. Cambridge: Cambridge University Press; pp. 293-300.
    • (1998) Introduction to the Blood-Brain Barrier , pp. 293-300
    • Rubin, L.1    Morgan, L.2    Staddon, J.M.3
  • 126
    • 0031060245 scopus 로고    scopus 로고
    • Relationship between immobilised artificial membrane chromatographic retention and the brain penetration of structurally diverse drugs
    • Salminen T, Pulli A, Taskinen J. 1997. Relationship between immobilised artificial membrane chromatographic retention and the brain penetration of structurally diverse drugs. J Pharm Biomed Anal 15:469-477.
    • (1997) J Pharm Biomed Anal , vol.15 , pp. 469-477
    • Salminen, T.1    Pulli, A.2    Taskinen, J.3
  • 127
    • 0027950804 scopus 로고
    • Blood-brain barrier transport of neuropeptides: Analysis with a metabolically stable dermorphin analogue
    • Samii A, Bickel U, Stroth U, Pardridge WM. 1994. Blood-brain barrier transport of neuropeptides: Analysis with a metabolically stable dermorphin analogue. Am J Physiol 267:E124-E131.
    • (1994) Am J Physiol , vol.267
    • Samii, A.1    Bickel, U.2    Stroth, U.3    Pardridge, W.M.4
  • 128
    • 0242302565 scopus 로고    scopus 로고
    • Blood-brain barrier transport of synthetic adenosine A1 receptor agonists in vitro: Structure transport relationships
    • Schaddelee MP, Voorwinden HL, Groenendaal D, Hersey A, Ijzerman AP, et al. 2003. Blood-brain barrier transport of synthetic adenosine A1 receptor agonists in vitro: Structure transport relationships. Eur J Pharm Sci 20(3):347-356.
    • (2003) Eur J Pharm Sci , vol.20 , Issue.3 , pp. 347-356
    • Schaddelee, M.P.1    Voorwinden, H.L.2    Groenendaal, D.3    Hersey, A.4    Ijzerman, A.P.5
  • 129
    • 0033526176 scopus 로고    scopus 로고
    • P-glycoprotein, a gatekeeper in the blood-brain barrier
    • Schinkel AH. 1999. P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv 36:179-194.
    • (1999) Adv Drug Deliv , vol.36 , pp. 179-194
    • Schinkel, A.H.1
  • 130
    • 0032930327 scopus 로고    scopus 로고
    • Structure-transport relationship for the intestinal small-peptides carrier: Is the carbonyl group of the peptide bond relevant for transport?
    • Schoenmakers RG, Stehouwer MC, Tukker JJ. 1999. Structure-transport relationship for the intestinal small-peptides carrier: Is the carbonyl group of the peptide bond relevant for transport? Pharm Res 16(1):62-68.
    • (1999) Pharm Res , vol.16 , Issue.1 , pp. 62-68
    • Schoenmakers, R.G.1    Stehouwer, M.C.2    Tukker, J.J.3
  • 131
    • 0032518454 scopus 로고    scopus 로고
    • A general pattern for substrate recognition by P-glycoprotein
    • Seelig A. 1998. A general pattern for substrate recognition by P-glycoprotein. Eur J Biochem 251:252-261.
    • (1998) Eur J Biochem , vol.251 , pp. 252-261
    • Seelig, A.1
  • 132
    • 0033739115 scopus 로고    scopus 로고
    • Structure-activity relationship of P-glycoprotein substrate and modifiers
    • Seelig A, Landwojtowicz E. 2000. Structure-activity relationship of P-glycoprotein substrate and modifiers. Eur J Pharm Sci 12:31-40.
    • (2000) Eur J Pharm Sci , vol.12 , pp. 31-40
    • Seelig, A.1    Landwojtowicz, E.2
  • 133
    • 0028158735 scopus 로고
    • A method to determine the ability of drugs to diffuse through the blood-brain barrier
    • Seelig A, Gottschlich R, Devant RM. 1994. A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc Natl Acad Sci USA 91, 68-72.
    • (1994) Proc Natl Acad Sci USA , vol.91 , pp. 68-72
    • Seelig, A.1    Gottschlich, R.2    Devant, R.M.3
  • 134
    • 0024325094 scopus 로고
    • The application of bovine brain microvessel endothelial-cell monolayers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier
    • Shah MV, Audus KL, Borchardt RT. 1989. The application of bovine brain microvessel endothelial-cell monolayers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier. Pharm Res 6(7):624-627.
    • (1989) Pharm Res , vol.6 , Issue.7 , pp. 624-627
    • Shah, M.V.1    Audus, K.L.2    Borchardt, R.T.3
  • 136
    • 0029759938 scopus 로고    scopus 로고
    • A dynamic model of the blood-brain barrier in vitro
    • Staness KA, Guatteo E, Janigro D. 1996. A dynamic model of the blood-brain barrier in vitro. Neurotoxicology 17(2):481-496.
    • (1996) Neurotoxicology , vol.17 , Issue.2 , pp. 481-496
    • Staness, K.A.1    Guatteo, E.2    Janigro, D.3
  • 137
    • 0015443562 scopus 로고
    • In vitro model for transport of solutes in three-phase system. I. Theoretical principles
    • Stehle RG, Higuchi WI. 1972. In vitro model for transport of solutes in three-phase system. I. Theoretical principles. J Pharm Sci 61(12):1922-1930.
    • (1972) J Pharm Sci , vol.61 , Issue.12 , pp. 1922-1930
    • Stehle, R.G.1    Higuchi, W.I.2
  • 138
    • 0033014577 scopus 로고    scopus 로고
    • Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties
    • Stenberg P, Luthman K, Artursson P. 1999. Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties. Pharm Res 16(2):205-212.
    • (1999) Pharm Res , vol.16 , Issue.2 , pp. 205-212
    • Stenberg, P.1    Luthman, K.2    Artursson, P.3
  • 139
    • 0037204543 scopus 로고    scopus 로고
    • Progress in understanding the structure-activity relationships of P-glycoprotein
    • Stouch TR, Gudmundsson O. 2002. Progress in understanding the structure-activity relationships of P-glycoprotein. Adv Drug Deliv Rev 54(3):315-328.
    • (2002) Adv Drug Deliv Rev , vol.54 , Issue.3 , pp. 315-328
    • Stouch, T.R.1    Gudmundsson, O.2
  • 140
    • 1542503699 scopus 로고    scopus 로고
    • Computational models to predict blood-brain barrier permeation and CNS activity
    • Subramanian G, Kitchen DB. 2003. Computational models to predict blood-brain barrier permeation and CNS activity. J Comput Aided Mol Des 17:643-664.
    • (2003) J Comput Aided Mol des , vol.17 , pp. 643-664
    • Subramanian, G.1    Kitchen, D.B.2
  • 141
    • 1842639123 scopus 로고    scopus 로고
    • A universal molecular descriptor system for prediction of LogP, LogS, LogBB and absorption
    • Sun H. 2004. A universal molecular descriptor system for prediction of LogP, LogS, LogBB and absorption. J Chem Inf Comput Sci 44:748-757.
    • (2004) J Chem Inf Comput Sci , vol.44 , pp. 748-757
    • Sun, H.1
  • 142
    • 0033756459 scopus 로고    scopus 로고
    • Transporter-mediated permeation of drugs across the blood-brain barrier
    • Tamai I, Tsuji A. 2000. Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci 89(11):1371-1388.
    • (2000) J Pharm Sci , vol.89 , Issue.11 , pp. 1371-1388
    • Tamai, I.1    Tsuji, A.2
  • 143
    • 0030948209 scopus 로고    scopus 로고
    • Structure-internalization relationship for adorptive-mediated endocytosis of basic peptides at the blood-brain barrier
    • Tamai I, Sai Y, Kobayashi H, Kamata M, Wakamiya T, et al. 1997. Structure-internalization relationship for adorptive-mediated endocytosis of basic peptides at the blood-brain barrier. J Pharmacol Exp Ther 280:410-415.
    • (1997) J Pharmacol Exp Ther , vol.280 , pp. 410-415
    • Tamai, I.1    Sai, Y.2    Kobayashi, H.3    Kamata, M.4    Wakamiya, T.5
  • 144
  • 146
    • 0141923651 scopus 로고    scopus 로고
    • New approaches to in vitro models of blood-brain barrier drug transport
    • Terasaki T, Ohtsuki S, Hori S, Takanaga H, Nakashima E, et al. 2003. New approaches to in vitro models of blood-brain barrier drug transport. Drug Discov Today 8(20):944-954.
    • (2003) Drug Discov Today , vol.8 , Issue.20 , pp. 944-954
    • Terasaki, T.1    Ohtsuki, S.2    Hori, S.3    Takanaga, H.4    Nakashima, E.5
  • 147
    • 0033526179 scopus 로고    scopus 로고
    • Carrier-mediated or specialized transport of drugs across the blood-brain barrier
    • Tsuji A, Tamai I. 1999. Carrier-mediated or specialized transport of drugs across the blood-brain barrier. Adv Drug Deliv Rev 36:277-290.
    • (1999) Adv Drug Deliv Rev , vol.36 , pp. 277-290
    • Tsuji, A.1    Tamai, I.2
  • 148
    • 0000796494 scopus 로고    scopus 로고
    • Molecular dissection of tight junctions: Occludin and ZO-1
    • Pardridge WM, editor. Cambridge: Cambridge University Press
    • Tsukita S, Furuse M, Itoh M. 1998. Molecular dissection of tight junctions: Occludin and ZO-1. Introduction to the Blood-Brain Barrier. Pardridge WM, editor. Cambridge: Cambridge University Press; pp. 322-329.
    • (1998) Introduction to the Blood-brain Barrier , pp. 322-329
    • Tsukita, S.1    Furuse, M.2    Itoh, M.3
  • 149
    • 0842304421 scopus 로고    scopus 로고
    • Phe-Gly dipeptidomimetics designed for the di-/tri-peptide transporters PEPT1 and PEPT2: Synthesis and biological investigations
    • Vabeno J, Lejon T, Nielsen CU, Steffansen B, Chen W, et al. 2004. Phe-Gly dipeptidomimetics designed for the di-/tri-peptide transporters PEPT1 and PEPT2: Synthesis and biological investigations. J Med Chem 47(4):1060-1069.
    • (2004) J Med Chem , vol.47 , Issue.4 , pp. 1060-1069
    • Vabeno, J.1    Lejon, T.2    Nielsen, C.U.3    Steffansen, B.4    Chen, W.5
  • 150
    • 34250243779 scopus 로고
    • Transport in QSAR. V: Application of the interfacial drug transfer model
    • Van de Waterbeemd H, Jansen A. 1981. Transport in QSAR. V: Application of the interfacial drug transfer model. Pharm Weekbl Sci Ed 3:587-594.
    • (1981) Pharm Weekbl Sci Ed , vol.3 , pp. 587-594
    • Van De Waterbeemd, H.1    Jansen, A.2
  • 151
    • 21144467893 scopus 로고
    • Hydrogen-bonding capacity and brain penetration
    • Van de Waterbeemd H, Kansy M. 1992. Hydrogen-bonding capacity and brain penetration. Chimia 46:299-303.
    • (1992) Chimia , vol.46 , pp. 299-303
    • Van De Waterbeemd, H.1    Kansy, M.2
  • 153
    • 0032410164 scopus 로고    scopus 로고
    • Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors
    • Van de Waterbeemd H, Camenish G, Folkers G, Chretien JR, Raevsky OA. 1998. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J Drug Target 6(2):151-165.
    • (1998) J Drug Target , vol.6 , Issue.2 , pp. 151-165
    • Van De Waterbeemd, H.1    Camenish, G.2    Folkers, G.3    Chretien, J.R.4    Raevsky, O.A.5
  • 154
    • 0035953319 scopus 로고    scopus 로고
    • Property-based design: Optimization of drug absorption and pharmacokinetics
    • Van de Waterbeemd H, Smith DA, Beaumont K, Walker DK. 2001. Property-based design: Optimization of drug absorption and pharmacokinetics. J Med Chem 44(9):1313-1333.
    • (2001) J Med Chem , vol.44 , Issue.9 , pp. 1313-1333
    • Van De Waterbeemd, H.1    Smith, D.A.2    Beaumont, K.3    Walker, D.K.4
  • 155
    • 0033556371 scopus 로고    scopus 로고
    • Differential binding of tropane-based photoaffinity ligands on the dopamine transporter
    • Vaughan RA, Agoston GE, Lever JR, Newman AH. 1999. Differential binding of tropane-based photoaffinity ligands on the dopamine transporter. The Journal of Neuroscience 19(2):630-636.
    • (1999) The Journal of Neuroscience , vol.19 , Issue.2 , pp. 630-636
    • Vaughan, R.A.1    Agoston, G.E.2    Lever, J.R.3    Newman, A.H.4
  • 156
    • 0030843601 scopus 로고    scopus 로고
    • Functional characterization of choiroid plexus epithelial cells in primary culture
    • Villalobos AR, Parmelee JT, Pritchard JB, 1997. Functional characterization of choiroid plexus epithelial cells in primary culture. J Pharmacol Exp Ther 282:1109-1116.
    • (1997) J Pharmacol Exp Ther , vol.282 , pp. 1109-1116
    • Villalobos, A.R.1    Parmelee, J.T.2    Pritchard, J.B.3
  • 157
    • 0030696102 scopus 로고    scopus 로고
    • An immuno-histochemical and morphometric study on asrtocytes and microbasculature in the human cerebral cortex
    • Virgintino D, Monaghan P, Robertson D. 1997. An immuno-histochemical and morphometric study on asrtocytes and microbasculature in the human cerebral cortex. Histochem J 29:655-660.
    • (1997) Histochem J , vol.29 , pp. 655-660
    • Virgintino, D.1    Monaghan, P.2    Robertson, D.3
  • 158
    • 0031981341 scopus 로고    scopus 로고
    • Design and synthesis of peptides passing through the blood-brain barrier
    • Wakamiya T, Kamata M, Kusumoto S, Kobayashi H, Sai Y, et al. 1998. Design and synthesis of peptides passing through the blood-brain barrier. Bull Chem Soc Jpn 78:699-709.
    • (1998) Bull Chem Soc Jpn , vol.78 , pp. 699-709
    • Wakamiya, T.1    Kamata, M.2    Kusumoto, S.3    Kobayashi, H.4    Sai, Y.5
  • 159
    • 0004844581 scopus 로고    scopus 로고
    • Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine
    • Wu D, Kang YS, Bickel U, Pardridge WM. 1997. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab Dispos 25(6):768-71.
    • (1997) Drug Metab Dispos , vol.25 , Issue.6 , pp. 768-771
    • Wu, D.1    Kang, Y.S.2    Bickel, U.3    Pardridge, W.M.4
  • 160
    • 0023902147 scopus 로고    scopus 로고
    • Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists
    • Young RC, Mitchell RC, Brown TH, Ganellin CR, Griffiths R, et al. 1998. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. J Med Chem 31:656-671.
    • (1998) J Med Chem , vol.31 , pp. 656-671
    • Young, R.C.1    Mitchell, R.C.2    Brown, T.H.3    Ganellin, C.R.4    Griffiths, R.5
  • 161
    • 0023898749 scopus 로고
    • Physico-chemical properties shared by compounds that modulate multidrug resistance un human leukemic cells
    • Zamora JM, Pearce HL, Beck WT. 1988. Physico-chemical properties shared by compounds that modulate multidrug resistance un human leukemic cells. Mol Pharmacol 33:454-462.
    • (1988) Mol Pharmacol , vol.33 , pp. 454-462
    • Zamora, J.M.1    Pearce, H.L.2    Beck, W.T.3
  • 163
    • 0032415136 scopus 로고    scopus 로고
    • Primary culture of choroidal epithelial cells: Characterization of an in vitro model of blood-CSF barrier
    • Zheng W, Zhao Q, Graziano JH. 1998. Primary culture of choroidal epithelial cells: Characterization of an in vitro model of blood-CSF barrier. In Vitro Cell Dev Biol Anim 34(1):40-45.
    • (1998) Vitro Cell Dev Biol Anim , vol.34 , Issue.1 , pp. 40-45
    • Zheng, W.1    Zhao, Q.2    Graziano, J.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.